Curexel Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $3.14M

  • Investors
  • 4

Curexel General Information

Description

Developer of a medical device designed for painless drug and diagnostic delivery. The company's technology enables drug and diagnostic administration through a needle-free approach designed for vaccination, intravenous access, cannulation, and other routine medical procedures, enabling healthcare providers to reduce needle-related pain and anxiety while supporting clinically efficient delivery and improving the overall experience for patients receiving care.

Contact Information

Website
www.curexel.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11/A, 5th Main, 2nd Cross, Pramoda Layout
  • Nayanadahalli, Bengaluru 560039
  • India
Primary Industry
Drug Delivery
Other Industries
Therapeutic Devices
Corporate Office
  • 11/A, 5th Main, 2nd Cross, Pramoda Layout
  • Nayanadahalli, Bengaluru 560039
  • India

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Curexel Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Seed Round 25-Aug-2026 $3.14M Completed Generating Revenue
3. Angel (individual) Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view Curexel’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Curexel Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Curexel Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
IN44 Capital Angel Group Minority
Peaceful Progress Angel Group Minority
10,000 Startups-NASSCOM Accelerator/Incubator
Venture Center Accelerator/Incubator
To view Curexel’s complete investors history, request access »

Ready to get started?

Request a free trial

Curexel FAQs

  • When was Curexel founded?

    Curexel was founded in 2023.

  • Where is Curexel headquartered?

    Curexel is headquartered in Nayanadahalli, India.

  • What is the size of Curexel?

    Curexel has 4 total employees.

  • What industry is Curexel in?

    Curexel’s primary industry is Drug Delivery.

  • Is Curexel a private or public company?

    Curexel is a Private company.

  • What is Curexel’s current revenue?

    The current revenue for Curexel is .

  • How much funding has Curexel raised over time?

    Curexel has raised $3.14M.

  • Who are Curexel’s investors?

    IN44 Capital, Peaceful Progress, 10,000 Startups-NASSCOM, and Venture Center have invested in Curexel.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process